Previous observation of severe COVID‐19 patients’ blood reported a reduced number of lymphocytes, especially T cells.[30] Furthermore, the exhaustion of CD8+ T cell in the COVID‐19 patients was also observed.[31] As engineered chimeric T cell technology relies on infusion of T cells, this can lead to immune activation and the reduced T cell can be replenished. This evidence concerns the gene CD8A and COVID-19.